Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Introduction to Epidemiology01:26

Introduction to Epidemiology

Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From challenge to innovation: a narrative review on innovation in nephrology and hemodialysis randomized trials.

Journal of nephrology·2026
Same author

Hemodiafiltration beyond the CONVINCE trial.

Clinical kidney journal·2026
Same author

Choice and impact of EQ-5D-5L value set in cost-utility analyses alongside multinational trials: Insights from PREFERABLE-EFFECT and CONVINCE.

PloS one·2026
Same author

A new chapter, a shared responsibility: building the next phase of Journal of Nephrology and strengthening its editorial community.

Journal of nephrology·2026
Same author

Association between Alcohol Consumption and All-Cause Mortality in Patients Undergoing Hemodialysis: A Survival Analysis from the DIET-HD Cohort.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Artificial intelligence in pediatric nephrology: current applications and emerging frameworks for evidence generation.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Paroxysmal Cold Haemoglobinuria: A Chilling Case of Acute Renal Failure.

Nephrology (Carlton, Vic.)·2026
Same journal

Optimising Therapeutic Target Attainment in Vancomycin Therapy for Patients Requiring Intermittent Haemodialysis.

Nephrology (Carlton, Vic.)·2026
Same journal

Injury to E- and VE-Cadherin in Paediatric Idiopathic Steroid-Sensitive Nephrotic Syndrome: Potential Markers of the Disease Status.

Nephrology (Carlton, Vic.)·2026
Same journal

Finerenone in Treating a 12-Year-Old Boy Suffering Gitelman Syndrome Without Causing Gynecomastia.

Nephrology (Carlton, Vic.)·2026
Same journal

NCOA4-Mediated Ferroptosis Drives Tubulointerstitial Fibrosis in Hyperuricemia-Associated Chronic Kidney Disease.

Nephrology (Carlton, Vic.)·2026
Same journal

Comment on 'Chronic Kidney Disease-Associated Pruritus in Patients on Home Haemodialysis'.

Nephrology (Carlton, Vic.)·2026
See all related articles

Related Experiment Video

Updated: Jun 7, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

How to read critically a prognostic cohort study.

Suetonia C Palmer1, Giovanni F M Strippoli

  • 1Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. suetoniapalmer@clear.net.nz

Nephrology (Carlton, Vic.)
|November 3, 2010
PubMed
Summary
This summary is machine-generated.

Cohort studies provide valuable data in nephrology for understanding disease prevalence, causes, and outcomes. This evaluation focuses on using cohort studies to improve prognosis predictions in kidney disease patients.

Related Experiment Videos

Last Updated: Jun 7, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Area of Science:

  • Nephrology
  • Clinical Epidemiology

Background:

  • Cohort studies are a primary data source in nephrology.
  • They are well-suited for investigating disease prevalence, etiology, and prognosis.

Purpose of the Study:

  • To evaluate the utility of cohort studies in guiding prognostic decisions within clinical nephrology.
  • To enhance the application of cohort data for patient outcome prediction.

Main Methods:

  • Review and analysis of existing cohort study methodologies in nephrology.
  • Assessment of how cohort data informs clinical decision-making regarding prognosis.

Main Results:

  • Cohort studies offer robust evidence for understanding disease trajectories.
  • Effective utilization of cohort data can significantly improve prognostic accuracy.

Conclusions:

  • Cohort studies are essential for advancing prognostic understanding in nephrology.
  • Optimizing the use of cohort studies aids in better patient management and outcomes.